Filing Details

Accession Number:
0001593968-21-001617
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-14 21:13:19
Reporting Period:
2021-06-10
Accepted Time:
2021-06-14 21:13:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX Pharmaceutical Preparations (2834) 270605902
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777760 Craig Andrew Miller C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-10 13,333 $9.20 58,833 No 4 M Direct
Common Stock Disposition 2021-06-10 13,333 $123.68 45,500 No 4 S Direct
Common Stock Acquisiton 2021-06-11 8,333 $9.20 53,833 No 4 M Direct
Common Stock Disposition 2021-06-11 8,333 $129.33 45,500 No 4 S Direct
Common Stock Acquisiton 2021-06-14 8,334 $9.20 53,834 No 4 M Direct
Common Stock Disposition 2021-06-14 8,334 $131.44 45,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-06-10 13,333 $0.00 13,333 $9.20
Common Stock Option (right to buy) Disposition 2021-06-11 8,333 $0.00 8,333 $9.20
Common Stock Option (right to buy) Disposition 2021-06-14 8,334 $0.00 8,334 $9.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
287,159 2029-03-20 No 4 M Direct
278,826 2029-03-20 No 4 M Direct
270,492 2029-03-20 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This option vests and becomes exercisable in thirty equal monthly installments beginning on March 21, 2019.